최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0928687 (2010-12-16) |
등록번호 | US-8545984 (2013-10-01) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 5 인용 특허 : 165 |
Described herein are compounds generally comprising an indeno2′,3′:3,4naptho1,2-bpyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials.
Described herein are compounds generally comprising an indeno2′,3′:3,4naptho1,2-bpyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials. Additionally, such compounds and/or compositions may be suitable for preparing certain photochromic articles. Also described herein are methods for preparing certain photochromic compounds, compositions, and articles.
1. A compound represented by the following graphic Formula I: wherein:A′ is selected from optionally substituted heteroaryl and optionally substituted aryl wherein A′ is optionally substituted with L2;R1 and R2 are each independently selected from hydrogen, hydroxy and chiral or achiral groups selec
1. A compound represented by the following graphic Formula I: wherein:A′ is selected from optionally substituted heteroaryl and optionally substituted aryl wherein A′ is optionally substituted with L2;R1 and R2 are each independently selected from hydrogen, hydroxy and chiral or achiral groups selected from optionally substituted heteroalkyl, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, halogen, optionally substituted amino, carboxy, alkylcarbonyl, alkoxycarbonyl, optionally substituted alkoxy, and aminocarbonyl, or R1 and R2 may be taken together with any intervening atoms to form a group selected from oxo, optionally substituted cycloalkyl, and optionally substituted heterocycloalkyl; andR3 for each occurrence, is independently selected from chiral or achiral groups selected from formyl, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, arylcarbonyl, aryloxycarbonyl, aminocarbonyloxy, alkoxycarbonylamino, aryloxycarbonylamino, boronic acid, boronic acid esters, cycloalkoxycarbonylamino, heterocycloalkyloxycarbonylamino, heteroaryloxycarbonylamino, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, halogen, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkoxy, optionally substituted heteroalkyl, optionally substituted heterocycloalkyl, and optionally substituted amino;m is an integer selected from 0 to 3;B and B′ are each independently selected from L3, hydrogen, halogen, and chiral or achiral groups selected from metallocenyl, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted heteroalkyl, optionally substituted alkoxy, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocycloalkyl, and optionally substituted cycloalkyl, or wherein B and B′ are taken together with any intervening atoms to form a group selected from optionally substituted cycloalkyl and optionally substituted heterocycloalkyl; andL1, L2, and L3 for each occurrence, are independently selected from a chiral or achiral lengthening group represented by: —[S1]c-[Q1-[S2]d]d′-[Q2-[S3]e]e′-[Q3-[S4]f]f′—S5—P wherein:(a) Q1, Q2, and Q3 for each occurrence, are independently selected from a divalent group selected from optionally substituted aryl, optionally substituted heteroaryl, optionally substituted cycloalkyl, and optionally substituted heterocycloalkyl;wherein substituents are independently selected from P, liquid crystal mesogens, halogen, poly(C1-C18 alkoxy), C1-C18 alkoxycarbonyl, C1-C18 alkylcarbonyl, C1-C18 alkoxycarbonyloxy, aryloxycarbonyloxy, perfluoro(C1-C18)alkoxy, perfluoro(C1-C18)alkoxycarbonyl, perfluoro(C1-C18)alkylcarbonyl, perfluoro(C1-C18)alkylamino, di-(perfluoro(C1-C18)alkyl)amino, perfluoro(C1-C18)alkylthio, C1-C18 alkylthio, C1-C18 acetyl, C3-C10 cycloalkyl, C3-C10 cycloalkoxy, straight-chain C1-C18 alkyl, and branched C1-C18 alkyl;wherein said straight-chain C1-C18 alkyl and branched C1-C18 alkyl are mono-substituted with a group selected from cyano, halogen, and C1-C18 alkoxy; orwherein said straight-chain C1-C18 alkyl and branched C1-C18 alkyl are poly-substituted with at least two groups independently selected from halogen, -M(T)(t-1) and -M(OT)(t-1), wherein M is chosen from aluminum, antimony, tantalum, titanium, zirconium and silicon, T is chosen from organofunctional radicals, organofunctional hydrocarbon radicals, aliphatic hydrocarbon radicals and aromatic hydrocarbon radicals, and t is the valence of M;(b) c, d, e, and f are each independently chosen from an integer from 1 to 20; and each S1, S2, S3, S4, and S5 is independently chosen for each occurrence from a spacer unit selected from: (i) optionally substituted alkylene, optionally substituted haloalkylene, —Si(CH2)g—, and —(Si[(CH3)2]O)h—, wherein g for each occurrence is independently chosen from an integer from 1 to 20; h for each occurrence is independently chosen from an integer from 1 to 16; and said substitutes for the alkylene and haloalkylene are independently selected from C1-C18 alkyl, C3-C10 cycloalkyl and aryl;(ii) —N(Z)—, —C(Z)=C(Z)—, —C(Z)═N—, —C(Z′)2—C(Z′)2—, and a single bond, wherein Z for each occurrence is independently selected from hydrogen, C1-C18 alkyl, C3-C10 cycloalkyl and aryl, and Z′ for each occurrence is independently selected from C1-C18 alkyl, C3-C10 cycloalkyl and aryl; and(iii) —O—, —C(═O)—, —N═N—, —S—, —S(═O)—, —(O═)S(═O)—, —(O═)S(═O)O—, —O(O═)S(═O)O— and straight-chain or branched C1-C24 alkylene residue, said C1-C24 alkylene residue being unsubstituted, mono-substituted by cyano or halogen, or poly-substituted by halogen,provided that when two spacer units comprising heteroatoms are linked together the spacer units are linked so that heteroatoms are not directly linked to each other, each bond between S1 and the compound represented by graphic Formula I is free of two heteroatoms linked together, and the bond between S5 and P is free of two heteroatoms linked to each other;(c) P for each occurrence is independently selected from hydroxy, amino, C2-C18 alkenyl, C2-C18 alkynyl, azido, silyl, siloxy, silylhydride, (tetrahydro-2H-pyran-2-yl)oxy, thio, isocyanato, thioisocyanato, acryloyloxy, methacryloyloxy, 2-(acryloyloxy)ethylcarbamyl, 2-(methacryloyloxy)ethylcarbamyl, aziridinyl, allyloxycarbonyloxy, epoxy, carboxylic acid, carboxylic ester, acryloylamino, methacryloylamino, aminocarbonyl, C1-C18 alkyl aminocarbonyl, aminocarbonyl(C1-C18)alkyl, C1-C18 alkyloxycarbonyloxy, halocarbonyl; hydrogen, aryl, hydroxy(C1-C18)alkyl, C1-C18 alkyl, C1-C18 alkoxy, amino(C1-C18)alkyl, C1-C18 alkylamino, di-(C1-C18)alkylamino, C1-C18 alkyl(C1-C18)alkoxy, C1-C18 alkoxy(C1-C18)alkoxy, nitro, poly(C1-C18)alkyl ether, (C1-C18)alkyl(C1-C18)alkoxy(C1-C18)alkyl, polyethyleneoxy, polypropyleneoxy, ethylene, acryloyl, acryloyloxy(C1-C18)alkyl, methacryloyl, methacryloyloxy(C1-C18)alkyl, 2-chloroacryloyl, 2-phenylacryloyl, acryloyloxyphenyl, 2-chloroacryloylamino, 2-phenylacryloylaminocarbonyl, oxetanyl, glycidyl, cyano, isocyanato(C1-C18)alkyl, itaconic acid ester, vinyl ether, vinyl ester, a styrene derivative, main-chain and side-chain liquid crystal polymers, siloxane derivatives, ethyleneimine derivatives, maleic acid derivatives, maleimide derivatives, fumaric acid derivatives, unsubstituted cinnamic acid derivatives, cinnamic acid derivatives that are substituted with at least one of methyl, methoxy, cyano and halogen, and substituted or unsubstituted chiral or non-chiral monovalent or divalent groups chosen from steroid radicals, terpenoid radicals, alkaloid radicals and mixtures thereof, wherein the substituents are independently chosen from C1-C18 alkyl, C1-C18 alkoxy, amino, C3-C10 cycloalkyl, C1-C18 alkyl(C1-C18)alkoxy, fluoro(C1-C18)alkyl, cyano, cyano(C1-C18)alkyl, cyano(C1-C18)alkoxy or mixtures thereof, or P is a structure having from 2 to 4 reactive groups or P is an unsubstituted or substituted ring opening metathesis polymerization precursor or P is a substituted or unsubstituted photochromic compound; and(d) d′, e′ and f′ are each independently chosen from 0, 1, 2, 3, and 4, provided that a sum of d′+e′+f′ is at least 2. 2. The compound of claim 1 represented by graphic Formula IA: whereinR4 is selected from hydrogen, R3 and L2; andn is an integer selected from 0 to 3. 3. The compound of claim 2, wherein R1 and R2 are each independently selected from hydrogen, hydroxy, and chiral and achiral groups selected from optionally substituted heteroalkyl, optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted cycloalkyl, halogen, optionally substituted amino, carboxy, alkylcarbonyl, alkoxycarbonyl, optionally substituted alkoxy, and aminocarbonyl or R1 and R2 may be taken together with any intervening atoms to form a group selected from oxo, optionally substituted cycloalkyl and optionally substituted heterocycloalkyl;R3 for each occurrence, is independently selected from formyl, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, arylcarbonyl, aryloxycarbonyl, optionally substituted alkyl, boronic acid ester, halogen, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted alkoxy, optionally substituted heteroalkyl, optionally substituted heterocycloalkyl and optionally substituted amino;m and n are each independently an integer selected from 0 to 2;B and B′ are each independently selected from L3 hydrogen, halogen, chiral or achiral groups selected from optionally substituted alkyl, optionally substituted alkenyl, optionally substituted heteroalkyl, optionally substituted alkoxy, optionally substituted aryl, optionally substituted heteroaryl, and optionally substituted cycloalkyl, or wherein B and B′ are taken together with any intervening atoms to form a group selected from optionally substituted cycloalkyl and optionally substituted heterocycloalkyl; andL1, L2, and L3 for each occurrence, are independently selected from a chiral or achiral lengthening group represented by:—[S1]c-[Q1-[S2]d]d′-[Q2-[S3]e]e′-[Q3-[S4]f]f′—S5—P wherein:(a) Q1, Q2, and Q3 for each occurrence, are independently selected from a divalent group selected from optionally substituted aryl and optionally substituted heteroaryl, optionally substituted cycloalkyl and optionally optionally substituted heterocycloalkyl; wherein substituents are independently selected from P, liquid crystal mesogens, halogen, poly(C1-C12 alkoxy), C1-C12 alkoxycarbonyl, C1-C12 alkylcarbonyl, perfluoro(C1-C12)alkoxy, perfluoro(C1-C12)alkoxycarbonyl, perfluoro(C1-C12)alkylcarbonyl, C1-C18 acetyl, C3-C7 cycloalkyl, C3-C7 cycloalkoxy, straight-chain C1-C12 alkyl, and branched C1-C12 alkyl, wherein said straight-chain C1-C12 alkyl and branched C1-C12 alkyl are mono-substituted with a group selected from, halogen, C1-C12 alkoxy, or wherein said straight-chain C1-C12 alkyl and branched C1-C12 alkyl are poly-substituted with at least two groups independently selected from halogen; (b) c, d, e, and f are each independently chosen from an integer from 1 to 10; and each S1, S2, S3, S4, and S5 is independently chosen for each occurrence from a spacer unit selected from: (i) substituted or unsubstituted alkylene, substituted or unsubstituted haloalkylene, —Si(CH2)g—, and —(Si[(CH3)2]O)h—, wherein g for each occurrence is independently chosen from an integer from 1 to 10; h for each occurrence is independently chosen from an integer from 1 to 8; and said substitutes for the alkylene and haloalkylene are independently selected from C1-C12 alkyl, C3-C7 cycloalkyl and phenyl;(ii) —N(Z)—, —C(Z)═C(Z)—, and a single bond, wherein Z for each occurrence is independently selected from hydrogen, C1-C12 alkyl, C3-C7 cycloalkyl and phenyl; and(iii) —O—, —C(═O)—, —N═N—, —S—, and —S(═O)—,provided that when two spacer units comprising heteroatoms are linked together the spacer units are linked so that heteroatoms are not directly linked to each other, each bond between S1 and the compound represented by graphic Formula IA is free of two heteroatoms linked together, and the bond between S5 and P is free of two heteroatoms linked to each other;(c) P for each occurrence is selected from hydroxy, amino, C2-C12 alkenyl, C2-C12 alkenyl, silyl, siloxy, (tetrahydro-2H-pyran-2-yl)oxy, isocyanato, acryloyloxy, methacryloyloxy, epoxy, carboxylic acid, carboxylic ester, C1-C12 alkyloxycarbonyloxy, halocarbonyl, hydrogen, aryl, hydroxy(C1-C12)alkyl, C1-C12 alkyl, C1-C12 alkoxy, ethylene, acryloyl, acryloyloxy(C1-C12)alkyl, methacryloyl, methacryloyloxy(C1-C12)alkyl, oxetanyl, glycidyl, vinyl ether, siloxane derivatives, unsubstituted cinnamic acid derivatives, cinnamic acid derivatives that are substituted with at least one of methyl, methoxy, cyano and halogen, and substituted or unsubstituted chiral or non-chiral monovalent or divalent groups chosen from steroid radicals, wherein each substituent is independently chosen from C1-C12 alkyl, C1-C12 alkoxy, amino, C3-C7 cycloalkyl, C1-C12 alkyl(C1-C12)alkoxy, or fluoro(C1-C12)alkyl, or P is a structure having from 2 to 4 reactive groups; and(d) d′, e′ and f′ are each independently chosen from 0, 1, 2, 3, and 4, provided that a sum of d′+e′+f is at least 2. 4. The compound of claim 3 wherein: R1 and R2 are each independently selected from hydrogen, hydroxy, and chiral groups selected from optionally substituted heteroalkyl, optionally substituted alkyl, optionally substituted aryl, optionally substituted cycloalkyl, halogen, carboxy, alkylcarbonyl, alkoxycarbonyl, optionally substituted alkoxy, and aminocarbonyl or R1 and R2 may be taken together with any intervening atoms to form a group selected from oxo and optionally substituted cycloalkyl; andR3 for each occurrence, is independently selected from alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, optionally substituted alkyl, boronic acid ester, halogen, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted alkoxy, optionally substituted heterocycloalkyl and optionally substituted amino;m and n are each independently an integer selected from 0 to 2;B and B′ are each independently selected from L3, hydrogen, chiral groups selected from optionally substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, optionally substituted heteroaryl, and optionally substituted cycloalkyl, or wherein B and B′ are taken together with any intervening atoms to form a group selected from optionally substituted cycloalkyl;L1, L2, and L3 for each occurrence, are independently selected from a chiral or achiral lengthening group represented by:—[S1]-[Q1—[S2]d]d′-[Q2—[S3]e]e′-[Q3—[S4]f]f′—S5—P wherein:(a) Q1, Q2, and Q3 for each occurrence, are independently selected from a divalent group selected from optionally substituted aryl and optionally substituted heteroaryl, optionally substituted cycloalkyl and optionally optionally substituted heterocycloalkyl;wherein substituents are independently selected from P, C1-C6alkoxycarbonyl, perfluoro(C1-C6)alkoxy, C3-C7 cycloalkyl, C3-C7 cycloalkoxy, straight-chain C1-C6 alkyl, and branched C1-C6 alkyl,wherein said straight-chain C1-C6 alkyl and branched C1-C6 alkyl are mono-substituted with a group selected from halogen and C1-C12 alkoxy, orwherein said straight-chain C1-C6 alkyl and branched C1-C6 alkyl are poly-substituted with at least two groups independently selected from halogen;(b) c, d, e, and f are each independently chosen from an integer from 1 to 10; and each S1, S2, S3, S4, and S5 is independently chosen for each occurrence from a spacer unit selected from: (i) substituted or unsubstituted alkylene;(ii) —N(Z)—, —C(Z)═C(Z)—, and a single bond, wherein Z for each occurrence is independently selected from hydrogen and C1-C6 alkyl; and(iii) —O—, —C(═O)—, —C≡C—, and —N═N—, —S—;provided that when two spacer units comprising heteroatoms are linked together the spacer units are linked so that heteroatoms of the first spacer unit are not directly linked to the heteroatoms of the second spacer unit, andprovided that when S1 and S5 are linked to Formula I and P, respectively, they are linked so that two heteroatoms are not directly linked to each other; (c) P for each occurrence is independently selected from hydroxy, amino, C2-C6 alkenyl, C2-C6 alkenyl, siloxy, (tetrahydro-2H-pyran-2-yl)oxy, isocyanato, acryloyloxy, methacryloyloxy, epoxy, carboxylic acid, carboxylic ester, C1-C6 alkyloxycarbonyloxy, hydrogen, aryl, hydroxy(C1-C6)alkyl, C1-C6 alkyl, ethylene, acryloyl, acryloyloxy(C1-C12)alkyl, oxetanyl, glycidyl, vinyl ether, siloxane derivatives, and substituted or unsubstituted chiral or non-chiral monovalent or divalent groups chosen from steroid radicals, wherein each substituent is independently chosen from C1-C6 alkyl, C1-C6 alkoxy, amino, C3-C7, cycloalkyl. 5. The compound of claim 4 wherein: R1 and R2 are each independently selected from methyl, ethyl, propyl and butyl; R3 and R4 for each occurrence are independently selected from methyl, ethyl, bromo, chloro, fluoro, methoxy, ethoxy and CF3, B and B′ are each independently selected from phenyl substituted with one or more groups independently selected from aryl, heteroaryl, heterocycloalkyl, alkyl, alkenyl, alkynyl, alkoxy, halogen, amino, alkylcarbonyl, carboxy, and alkoxycarbonyl; and for L1: Q1 is unsubstituted aryl; e′ is 1 or 2; e each occurrence is 1; S3 for each occurrence is a single bond; Q2 for each occurrence is independently selected from optionally substituted aryl; f′ is 1; f is 1; S4 is a single bond; and Q3 is optionally substituted cycloalkyl; S5 is —(CH2)g—, wherein g is an integer from 1 to 20; and P is hydrogen. 6. The compound of claim 1 wherein L1 is selected from: 4-[4-(4-butyl-cyclohexyl)-phenyl]-cyclohexyloxy;4″-butyl-[1,1′,4′,1″]tercyclohexan-4-yloxy;4-[4-(4-butyl-phenyl)-cyclohexyloxycarbonyl]-phenoxy;4′-(4-butyl-benzoyloxy)-biphenyl-4-carbonyloxy;4-(4-pentyl-phenylazo)-phenylcarbamoyl;4-(4-dimethylamino-phenylazo)-phenylcarbamoyl;4-[5-(4-propyl-benzoyloxy)-pyrimidin-2-yl]-phenyl4-[2-(4′-methyl-biphenyl-4-carbonyloxy)-1,2-diphenyl-ethoxycarbonyl]-phenyl;4-(1,2-diphenyl-2-{3-[4-(4-propyl-benzoyloxy)-phenyl]-acryloyloxy}-ethoxycarbonyl)-phenyl;4-[4-(4-{4-[3-(6-{4-[4-(4-nonyl-benzoyloxy)-phenoxycarbonyl]-phenoxy}-hexyloxycarbonyl)propionyloxy]-benzoyloxy}-benzoyloxy)phenyl]-piperazin-1-yl;4-[4-(4-{4-[4-(4-nonyl-benzoyloxy)-benzoyloxy]-benzoyloxy}-benzoyloxy)-phenyl]-piperazin-1-yl;4-(4′-propyl-biphenyl-4-ylethynyl)-phenyl;4-(4-fluoro-phenoxycarbonyloxy)-piperidin-1-yl;2-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11, 12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy]-indan-5-yl;4-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11, 12,13,14,15,16,17-tetradecahydro-1H-cyclopenta phenanthren-3-yloxycarbonyloxy]-piperidin-1-yl;4-(biphenyl-4-carbonyloxy)-piperidin-1-yl;4-(naphthalene-2-carbonyloxy)-piperidin-1-yl;4-(4-phenylcarbamoyl-phenylcarbamoyl)-piperidin-1-yl;4-(4-(4-phenylpiperidin-1-yl)-benzoyloxy)-piperidin-1-yl;4-butyl-[1,1′;4′,1″]terphenyl-4-yl;4-(4-pentadecafluoroheptyloxy-phenylcarbamoyl)-benzyloxy;4-(3-piperidin-4-yl-propyl)-piperidin-1-yl;4-(4-{4-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonyloxy]-benzoyloxy}-phenoxycarbonyl)phenoxymethyl;4-[4-(4-cyclohexyl-phenylcarbamoyl)-benzyloxy]-piperidin-1-yl;4-[4-(4-cyclohexyl-phenylcarbamoyl)-benzoyloxy]-piperidin-1-yl;N-{4-[(4-pentyl-benzylidene)amino]-phenyl}-acetamidyl;4-(3-piperidin-4-yl-propyl)piperidin-1-yl;4-(4-hexyloxy-benzoyloxy)-piperidin-1-yl;4-(4′-hexyloxy-biphenyl-4-carbonyloxy)-piperidin-1-yl;4-(4-butyl-phenylcarbamoyl)-piperidin-1-yl;4-[4-[4-[4-piperidinyl-4-oxy]-phenyl]phenoxy)piperidin-4-yl;4-(4-(9-(4-butylphenyl)-2,4,8,10-tetraoxaspiro[5.5]undec-3-yl)phenyl)piperazin-1-yl;4-(6-(4-butylphenyl)carbonyloxy-(4,8-dioxabicyclo[3.3.0]oct-2-yl))oxycarbonyl)phenyl;1-{4-[5-(4-butyl-phenyl)-[1,3]dioxan-2-yl]-phenyl}-4-methyl-piperazin-1-yl;4-(7-(4-propylphenylcarbonyloxy)bicyclo[3.3.0]oct-2-yl) oxycarbonyl)phenyl;4-[17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11, 12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxycarbonyloxy;(4-trans-(4-pentylcyclohexyl)benzamido)phenyl;(4-(4-trans-(4-pentylcyclohexyl)phenoxy)carbonyl)phenyl;4-(4-(4-trans-(4-pentylcyclohexyl)phenyl)benzamido)phenyl;4-((trans-(4′-pentyl-[1,1′-bi(cyclohexan)]-4-yl)oxy)carbonyl)phenyl;4-(4′-(4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl;4-((4(4′-(4-pentylcyclohexyl)-[1,1′-biphenyl]-4-carbonyl)oxy)benzamido;4-(4′-(4-pentylcyclohexyl)-[1,1′-biphenyl]-4-carbonyl)piperazin-1-yl;4-(4-(4-(4-pentylcyclohexyl)phenyl)benzamido)-2-(trifluoromethyl)phenyl;2-methyl-4-trans-(4-((4′-trans-(4-pentylcyclohexyl)biphenyl-4-yloxy)carbonyl)cyclohexanecarboxamido)phenyl;4′-((1r,1′s,4R,4′R)-4′-pentylbi(cyclohexane-4-)carbonyloxy)biphenylcarbonyloxy;4-(((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-(R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)carbonyl)piperazin-1-yl; and4-((S)-2-methylbutoxy)phenyl)-10-(4-(((3R,3aS,6S,6aS)-6-(4′-trans-(4-pentylcyclohexyl)biphenylcarbonyloxy)hexahydrofuro[3,2-b]furan-3-yloxy)carbonyl)phenyl. 7. The compound of claim 1 selected from: 3,3-Bis(4-methoxyphenyl)-10-[4-(4-(trans-4-pentylcyclohexyl)benzamido)phenyl]-13,13-dimethyl-12-bromo-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10-[4-((4-(trans-4-pentylcyclohexyl)phenoxy)carbonyl)phenyl]-6,13,13-trimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Fluorophenyl)-3-(4-piperidinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido) phenyl]-6-trifluoromethyl-11,13,13-trimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10-[4-(4-(trans-4-pentylcyclohexyl)benzamido)phenyl]-5,7-difluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Methoxyphenyl)-3-(4-piperidinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido) phenyl]-5,7-difluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Methoxyphenyl)-3-(4-morpholinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-5,7-difluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Fluorophenyl)-3-(4-piperidinophenyl)-10-[4-((4-(trans-4-pentylcyclohexyl)phenoxy)carbonyl)phenyl]-12-bromo-5,7-difluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-Phenyl-3-(4-piperidinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-12-bromo-5,7-difluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-Phenyl-3-(4-piperidinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenoxy)carbonyl)phenyl]-12-bromo-5,7-difluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Fluorophenyl)-3-(4-piperidinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-12-bromo-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxydinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-12-bromo-6,7-dimethoxy-11,13,13-trimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido) phenyl]-6-trifluoromethyl-12-bromo-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10,12-bis[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-6-trifluoromethyl-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-5,7-difluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido) phenyl]-6-trifluoromethyl-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-5,7-difluoro-12-bromo-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Fluorophenyl)-3-(4-morpholinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-6-trifluoromethyl-13-methyl-13-butyl-3,13-dihydro-indeno[2′, 3′:3,4]naphtho[1,2-b]pyran;3-(4-Fluorophenyl)-3-(4-morpholinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-5,7-difluoro-12-bromo-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-Phenyl-3-(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-6-trifluoromethyl-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-Phenyl-3-(4-morpholinophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-6-trifluoromethyl-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-fluorophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-6-trifluoromethyl-12-bromo-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-fluorophenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-6-trifluoromethyl-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Methoxyphenyl)-3-(4-butoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-6-trifluoromethyl-13,13-dimethyl-3,13-dihydro-indeno[2′, 3′:3,4]naphtho[1,2-b]pyran;3-(4-Fluorophenyl)-13,13-dimethyl-3-(4-morpholinophenyl)-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Butoxyphenyl)-3-(4-fluorophenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-(4-(4-Methoxyphenyl)piperazin-1-yl)phenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-3-phenyl-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Butoxyphenyl)-3-(4-fluorophenyl)-13,13-dimethyl-10-(4-(((trans,trans-4′-pentyl-[1,1′-bi(cyclohexan)]-4-yl)oxy)carbonyl)phenyl)-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Fluorophenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-3-(4-butoxyphenyl)-6-(trifluoromethyl)-3,13-dihydro indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Methoxyphenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-3-(4-(trifluoromethoxy)phenyl)-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-hydroxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido) phenyl]-6-trifluoromethyl-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;12-Bromo-3-(4-butoxyphenyl)-3-(4-fluorophenyl)-13,13-dimethyl-10-(4-((4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-carbonyl)oxy)benzamido)-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Butoxyphenyl)-5,7-dichloro-11-methoxy-3-(4-methoxyphenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Butoxyphenyl)-3-(4-fluorophenyl)-13,13-dimethyl-10-(4-((4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-carbonyl)oxy)benzamido)-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;5,7-Dichloro-3,3-bis(4-hydroxyphenyl)-11-methoxy-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;6,8-Dichloro-3,3-bis(4-hydroxyphenyl)-11-methoxy-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Butoxyphenyl)-5,8-difluoro-3-(4-fluorophenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-ylcarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Butoxyphenyl)-3-(4-fluorophenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)-[1,1′-biphenyl]-4-carbonyl)piperazin-1-yl)-6-(trifluoromethyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Morpholinophenyl)-3-(4-methoxyphenyl)-10,7-bis[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)phenyl]-5-fluoro-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Morpholinophenyl)-3-(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)-2-(trifluoromethyl)phenyl]-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenyl)benzamido)-2-(trifluoromethyl)phenyl]-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Morpholinophenyl)-3-(4-methoxyphenyl)-10-[4-(4-(4-(trans-4-pentylcyclohexyl)phenypbenzamido)-2-(trifluoromethyl)phenyl]-13,13-dimethyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3,3-Bis(4-methoxyphenyl)-13,13-dimethyl-10-(2-methyl-4-(trans-4-((4′-((trans-4-pentylcyclohexyl)biphenyl-4-yloxy)carbonyl)cyclohexanecarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-(4-(4-Butylphenyl)piperazin-1-yl)phenyl)-3-(4-methoxyphenyl)-13,13-dimethyl-10-(4-(4′-(trans-4-pentylcyclohexyl)biphenyl-4-ylcarboxamido)-2-(trifluoromethyl)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-(4-(4-Butylphenyl)piperazin-1-yl)phenyl)-3-(4-methoxyphenyl)-13,13-dimethyl-10-(2-methyl-4-(4′-(trans-4-pentylcyclohexyl)biphenyl-4-ylcarboxamido)phenyl)-7-(4-(4-(trans-4-pentylcyclohexyl)benzamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-(4-Methoxyphenyl)-13,13-dimethyl-7,10-bis(4-(4′-(trans-4-pentylcyclohexyl)biphenyl-4-ylcarboxamido)phenyl)-3-phenyl-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;3-p-Tolyl-3-(4-methoxyphenyl)-6-methoxy-13,13-dimethyl-7-(4′-(trans,trans-4′-pentylbi(cyclohexane-4-)carbonyloxy)biphenylcarbonyloxy)-10-(4-(4′-(trans-4-pentylcyclohexyl)biphenyl-4-ylcarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;10-(4-(((3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-(R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)carbonyl)piperazin-1-yl)-3-(4-methoxyphenyl)-13,13-dimethyl-3-(4-morpholinophenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;6-Methoxy-3-(4-methoxyphenyl)-13,13-dimethyl-3-(4-((S)-2-methylbutoxy)phenyl)-10-(4-(4′-(trans-4-pentylcyclohexyl)biphenyl-4-ylcarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran;6-Methoxy-3-(4-methoxyphenyl)-13,13-dimethyl-3-(4-((S)-2-methylbutoxy)phenyl)-7-(4′-(trans,trans-4′-pentylbi(cyclohexane-4-)carbonyloxy)biphenylcarbonyloxy)-10-(4-(4′-(trans-4-pentylcyclohexyl)biphenyl-4-ylcarboxamido)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran; and6-Methoxy-3-(4-methoxyphenyl)-13,13-dimethyl-3-(4-((S)-2-methylbutoxy)phenyl)-10-(4-(((3R,3aS,6S,6aS)-6-(4′-(trans-4-pentylcyclohexyl)biphenylcarbonyloxy)hexahydrofuro[3,2-b]furan-3-yloxy)carbonyl)phenyl)-3,13-dihydro-indeno[2′,3′:3,4]naphtho[1,2-b]pyran. 8. The compound of claim 1, wherein said compound is a photochromic compound. 9. A photochromic composition comprising the compound of claim 8 and optionally at least one other photochromic compound, wherein said composition comprises: (a) a single photochromic compound;(b) a mixture of photochromic compounds;(c) a material comprising at least one photochromic compound;(d) a material to which at least one photochromic compound is chemically bonded;(e) material (c) or (d) further comprising a coating to substantially prevent contact of the at least one photochromic compound with external materials;(f) a photochromic polymer; or(g) mixtures thereof. 10. A photochromic composition comprising at least one compound of claim 8 incorporated into at least a portion of an organic material, said organic material being a polymeric material, an oligomeric material, a monomeric material or a mixture or combination thereof. 11. The photochromic composition of claim 10 wherein said polymeric material comprises liquid crystal materials, self-assembling materials, polycarbonate, polyamide, polyimide, poly(meth)acrylate, polycyclic alkene, polyurethane, poly(urea)urethane, polythiourethane, polythio(urea)urethane, polyol(allyl carbonate), cellulose acetate, cellulose diacetate, cellulose triacetate, cellulose acetate propionate, cellulose acetate butyrate, polyalkene, polyalkylene-vinyl acetate, poly(vinylacetate), poly(vinyl alcohol), poly(vinyl chloride), poly(vinylformal), poly(vinylacetal), poly(vinylidene chloride), polyethylene terephthalate), polyester, polysulfone, polyolefin, copolymers thereof, and/or mixtures thereof. 12. The photochromic composition of claim 10 wherein the photochromic composition further comprises at least one additive chosen from dyes, alignment promoters, antioxidants, kinetic enhancing additives, photoinitiators, thermal initiators, polymerization inhibitors, solvents, light stabilizers, heat stabilizers, mold release agents, rheology control agents, leveling agents, free radical scavengers, gelators and adhesion promoters. 13. The photochromic composition of claim 10 comprising a coating composition chosen from liquid crystal materials, self-assembling materials and film forming materials. 14. A photochromic article comprising a substrate and a photochromic compound according to claim 8 connected to at least a portion of a substrate. 15. The photochromic article of claim 14 comprising an optical element, said optical element being at least one of an ophthalmic element, a display element, a window, a mirror, packaging material and an active or passive liquid crystal cell element. 16. The photochromic article of claim 15, wherein the ophthalmic element comprises corrective lenses, non-corrective lenses, contact lenses, intra-ocular lenses, magnifying lenses, protective lenses, or visors. 17. The photochromic article of claim 14 wherein the substrate comprises a polymeric material and the photochromic material is incorporated into at least a portion of the polymeric material. 18. The photochromic article of claim 17 wherein the photochromic material is blended with at least a portion of the polymeric material, bonded to at least a portion of the polymeric material, and/or imbibed into at least a portion of the polymeric material. 19. The photochromic article of claim 14 wherein the photochromic article comprises a coating or film connected to at least a portion of the substrate, said coating or film comprising the photochromic material. 20. The photochromic article of claim 19 wherein said substrate is formed from organic materials, inorganic materials, or combinations thereof. 21. The photochromic article of claim 14 further comprising at least one additional at least partial coating chosen from photochromic coatings, anti-reflective coatings, linearly polarizing coatings, transitional coatings, primer coatings, adhesive coatings, reflective coatings, antifogging coatings, oxygen barrier coatings, ultraviolet light absorbing coatings, and protective coatings. 22. A photochromic article comprising a substrate;at least a partial coating of one alignment material;at least one additional at least partial coating of a liquid crystal material; andat least one compound of claim 8. 23. The photochromic article of claim 22 further comprising at least one additive chosen from dichroic dyes, non-dichroic dyes, alignment promoters, antioxidants, kinetic enhancing additives, photoinitiators, thermal initiators, polymerization inhibitors, solvents, light stabilizers, heat stabilizers, mold release agents, rheology control agents, leveling agents, free radical scavengers, gelators and adhesion promoters. 24. The photochromic article of claim 22, wherein the substrate is selected from glass, quartz, and polymeric organic materials. 25. The photochromic article of claim 22, wherein the at least one alignment material comprises a polymer network orientable by exposure to at least one of: a magnetic field, an electric field, linearly polarized infrared radiation, linearly polarized ultraviolet radiation, linearly polarized visible radiation and a shear force. 26. The photochromic article of claim 22, wherein said liquid crystal material is a liquid crystal polymer. 27. The photochromic article of claim 22, further comprising at least one primer coating, transitional coating, protective coating or a combination thereof. 28. The photochromic article of claim 27, wherein the transitional coating comprises an acrylate polymer. 29. The photochromic article of claim 27, wherein the protective coating comprises at least one siloxane derivative. 30. The photochromic article of claim 27, wherein the at least one primer coating comprises a polyurethane.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.